New York State Common Retirement Fund’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

New York State Common Retirement Fund’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,500	Closed	-$31K	–	3350
2019 Q1	$31K	Hold	13,500	–	–	﹤0.01%	3113
2018 Q4	$31K	Hold	13,500	–	–	﹤0.01%	3131
2018 Q3	$200K	Hold	13,500	–	–	﹤0.01%	2825
2018 Q2	$205K	Buy	13,500 +2,200	+19%	+$37.3K	﹤0.01%	2860
2018 Q1	$212K	Buy	11,300 +4,400	+64%	+$76.9K	﹤0.01%	2709
2017 Q4	$125K	Buy	+6,900	New	+$146K	﹤0.01%	2932

Other funds holding SNNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New York State Common Retirement Fund's SNNA Position: Q2 2019 in Review

New York State Common Retirement Fund sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q2 2019, closing a stake of 13,500 shares — an estimated $31K sold.

New York State Common Retirement Fund first reported a position in SNNA in Q4 2017 and held it in 6 quarters. The position peaked at $212K in Q1 2018. 48 funds tracked by Wall St. Rank hold SNNA as of Q2 2019.

New York State Common Retirement Fund reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
New York State Common Retirement Fund sold 13,500 Sienna Biopharmaceuticals, Inc. shares in Q2 2019, an estimated $31K.
New York State Common Retirement Fund first reported a position in Sienna Biopharmaceuticals, Inc. in Q4 2017 and held it in 6 quarters.
New York State Common Retirement Fund's Sienna Biopharmaceuticals, Inc. position peaked at $212K in Q1 2018.
48 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q2 2019.

Based on New York State Common Retirement Fund's 13F filing for Q2 2019, filed 9 Aug 2019.